| Dr Lori Greene, MD | |
|
10350 E Dakota Ave, Denver, CO 80247-1314 | |
| (303) 338-3800 | |
| Not Available |
| Full Name | Dr Lori Greene |
|---|---|
| Gender | Female |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 10350 E Dakota Ave, Denver, Colorado |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013051721 | NPI | - | NPPES |
| 01263631 | Medicaid | CO | |
| 005939 | Other | CO | KAISER-COMMERCIAL NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 26363 (Colorado) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Lori Greene, MD 10350 E Dakota Ave, Denver, CO 80247-1314 Ph: (303) 338-3800 | Dr Lori Greene, MD 10350 E Dakota Ave, Denver, CO 80247-1314 Ph: (303) 338-3800 |
News Archive
Halozyme Therapeutics, Inc. today announced dose response study results that demonstrated faster insulin absorption and increased peak insulin concentrations after co-administration of its recombinant hyaluronidase enzyme (rHuPH20 or PH20) with regular human insulin and with insulin lispro. The enhanced absorption effects were observed at clinically relevant insulin doses across a broad range of PH20 concentrations.
CorMatrix Cardiovascular, Inc., a medical device company dedicated to developing and delivering unique extracellular matrix (ECM) biomaterial devices that harness the body's innate ability to repair damaged cardiovascular tissue, today announced that the Company has been awarded $2.3 million in grants under the U.S. Government's Qualifying Therapeutic Discovery Project (QTDP) program to advance the development of their unique ECM technology.
Findings from a new study on Alzheimer's disease (AD), led by researchers at the University of Saskatchewan, could eventually help clinicians identify people at highest risk for developing the irreversible, progressive brain disorder and pave the way for treatments that slow or prevent its onset.
The number of cases of poliomyelitis per year in Pakistan and Afghanistan has more than doubled since 2006 despite improvements in available vaccine efficacy, show study findings in The Lancet.
Covidien plc today reported results for the second quarter of fiscal 2013 (January - March 2013). Second-quarter net sales of $3.10 billion increased 5% from the $2.95 billion reported in the second quarter a year ago. Foreign exchange rate movement lowered the quarterly sales growth rate by two percentage points.
› Verified 7 days ago
Stefan Michael Bumol, Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4455 E 12th Ave, Denver, CO 80220 Phone: 303-504-7700 | |
Dr. Todd M. Kline, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 155 S Madison St, 216, Denver, CO 80209 Phone: 720-360-6375 | |
Gary Lee Martz, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1721 E 19th Ave, Suite 528, Denver, CO 80218 Phone: 303-813-1400 Fax: 303-813-1401 | |
Dr. Jeffrey Lee Metzner, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 3300 E 1st Ave, Suite 590, Denver, CO 80206 Phone: 303-355-6842 Fax: 303-322-2155 | |
James Trevor Mcnutt, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 4545 E 9th Ave, Suite 510, Denver, CO 80220 Phone: 303-321-0700 Fax: 303-321-0811 | |
Dr. Katherine Riva, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 777 Bannock St, Denver, CO 80204 Phone: 303-724-6019 |